Spinal muscular atrophy: Classification, diagnosis, management, pathogenesis, and future research directions

Felina V. Kostova, Virginia C. Williams, Jill Heemskerk, Susan Iannaccone, Christine DiDonato, Kathryn Swoboda, Bernard L. Maria

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Spinal muscular atrophy is an autosomal recessive neurodegenerative disorder that affects the motor neurons responsible for movement of the proximal muscles of the trunk and body. To date, the disease can be classified into 3 main categories based on severity and age of onset. During the October 18th symposium held in Pittsburgh, Pennsylvania, researchers met to (1) describe current diagnostic strategies, (2) discuss recent thoughts on pathogenesis, (3) review current therapies and clinical trials, and (4) define future research directions. In her opening remarks, Dr Story Landis, director of the National Institute of Neurological Disorders and Stroke, emphasized the degree to which the Neurobiology of Disease in Children conference series has broadened awareness of the many rare diseases affecting children, not only through the advancement of research but also by educating practitioners about diagnostic strategies. Dr Landis also discussed the role this conference may play in fostering research that seeks to develop a single mechanism of therapy for spinal muscular atrophy. She also discussed the current funding situation at the National Institutes of Health and addressed the crucial function of volunteer research organizations that sponsor research in further improving management of this condition. This article summarizes the presentations and includes the verbatim edited transcript of question-and-answer sessions.

Original languageEnglish (US)
Pages (from-to)926-945
Number of pages20
JournalJournal of Child Neurology
Volume22
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Spinal Muscular Atrophy
Research
National Institute of Neurological Disorders and Stroke
Foster Home Care
Neurobiology
National Institutes of Health (U.S.)
Motor Neurons
Rare Diseases
Age of Onset
Neurodegenerative Diseases
Volunteers
Research Personnel
Clinical Trials
Organizations
Muscles
Direction compound
Therapeutics

Keywords

  • Clinical features
  • Future research directions
  • Pathogenesis
  • Spinal muscular atrophy

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Spinal muscular atrophy : Classification, diagnosis, management, pathogenesis, and future research directions. / Kostova, Felina V.; Williams, Virginia C.; Heemskerk, Jill; Iannaccone, Susan; DiDonato, Christine; Swoboda, Kathryn; Maria, Bernard L.

In: Journal of Child Neurology, Vol. 22, No. 8, 08.2007, p. 926-945.

Research output: Contribution to journalArticle

Kostova, Felina V. ; Williams, Virginia C. ; Heemskerk, Jill ; Iannaccone, Susan ; DiDonato, Christine ; Swoboda, Kathryn ; Maria, Bernard L. / Spinal muscular atrophy : Classification, diagnosis, management, pathogenesis, and future research directions. In: Journal of Child Neurology. 2007 ; Vol. 22, No. 8. pp. 926-945.
@article{1e1f49f2887c45ffac018fdced7f7947,
title = "Spinal muscular atrophy: Classification, diagnosis, management, pathogenesis, and future research directions",
abstract = "Spinal muscular atrophy is an autosomal recessive neurodegenerative disorder that affects the motor neurons responsible for movement of the proximal muscles of the trunk and body. To date, the disease can be classified into 3 main categories based on severity and age of onset. During the October 18th symposium held in Pittsburgh, Pennsylvania, researchers met to (1) describe current diagnostic strategies, (2) discuss recent thoughts on pathogenesis, (3) review current therapies and clinical trials, and (4) define future research directions. In her opening remarks, Dr Story Landis, director of the National Institute of Neurological Disorders and Stroke, emphasized the degree to which the Neurobiology of Disease in Children conference series has broadened awareness of the many rare diseases affecting children, not only through the advancement of research but also by educating practitioners about diagnostic strategies. Dr Landis also discussed the role this conference may play in fostering research that seeks to develop a single mechanism of therapy for spinal muscular atrophy. She also discussed the current funding situation at the National Institutes of Health and addressed the crucial function of volunteer research organizations that sponsor research in further improving management of this condition. This article summarizes the presentations and includes the verbatim edited transcript of question-and-answer sessions.",
keywords = "Clinical features, Future research directions, Pathogenesis, Spinal muscular atrophy",
author = "Kostova, {Felina V.} and Williams, {Virginia C.} and Jill Heemskerk and Susan Iannaccone and Christine DiDonato and Kathryn Swoboda and Maria, {Bernard L.}",
year = "2007",
month = "8",
doi = "10.1177/0883073807305662",
language = "English (US)",
volume = "22",
pages = "926--945",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Spinal muscular atrophy

T2 - Classification, diagnosis, management, pathogenesis, and future research directions

AU - Kostova, Felina V.

AU - Williams, Virginia C.

AU - Heemskerk, Jill

AU - Iannaccone, Susan

AU - DiDonato, Christine

AU - Swoboda, Kathryn

AU - Maria, Bernard L.

PY - 2007/8

Y1 - 2007/8

N2 - Spinal muscular atrophy is an autosomal recessive neurodegenerative disorder that affects the motor neurons responsible for movement of the proximal muscles of the trunk and body. To date, the disease can be classified into 3 main categories based on severity and age of onset. During the October 18th symposium held in Pittsburgh, Pennsylvania, researchers met to (1) describe current diagnostic strategies, (2) discuss recent thoughts on pathogenesis, (3) review current therapies and clinical trials, and (4) define future research directions. In her opening remarks, Dr Story Landis, director of the National Institute of Neurological Disorders and Stroke, emphasized the degree to which the Neurobiology of Disease in Children conference series has broadened awareness of the many rare diseases affecting children, not only through the advancement of research but also by educating practitioners about diagnostic strategies. Dr Landis also discussed the role this conference may play in fostering research that seeks to develop a single mechanism of therapy for spinal muscular atrophy. She also discussed the current funding situation at the National Institutes of Health and addressed the crucial function of volunteer research organizations that sponsor research in further improving management of this condition. This article summarizes the presentations and includes the verbatim edited transcript of question-and-answer sessions.

AB - Spinal muscular atrophy is an autosomal recessive neurodegenerative disorder that affects the motor neurons responsible for movement of the proximal muscles of the trunk and body. To date, the disease can be classified into 3 main categories based on severity and age of onset. During the October 18th symposium held in Pittsburgh, Pennsylvania, researchers met to (1) describe current diagnostic strategies, (2) discuss recent thoughts on pathogenesis, (3) review current therapies and clinical trials, and (4) define future research directions. In her opening remarks, Dr Story Landis, director of the National Institute of Neurological Disorders and Stroke, emphasized the degree to which the Neurobiology of Disease in Children conference series has broadened awareness of the many rare diseases affecting children, not only through the advancement of research but also by educating practitioners about diagnostic strategies. Dr Landis also discussed the role this conference may play in fostering research that seeks to develop a single mechanism of therapy for spinal muscular atrophy. She also discussed the current funding situation at the National Institutes of Health and addressed the crucial function of volunteer research organizations that sponsor research in further improving management of this condition. This article summarizes the presentations and includes the verbatim edited transcript of question-and-answer sessions.

KW - Clinical features

KW - Future research directions

KW - Pathogenesis

KW - Spinal muscular atrophy

UR - http://www.scopus.com/inward/record.url?scp=34548165592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548165592&partnerID=8YFLogxK

U2 - 10.1177/0883073807305662

DO - 10.1177/0883073807305662

M3 - Article

C2 - 17761647

AN - SCOPUS:34548165592

VL - 22

SP - 926

EP - 945

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 8

ER -